Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Clinical applications of (18)F-FDG in oncology Nabi HA; Zubeldia JMJ Nucl Med Technol 2002[Mar]; 30 (1): 3-9; quiz 10-1PET has emerged as a powerful diagnostic tool for the evaluation of cancer patients. Currently, most of these studies are performed with the glucose analog (18)F-FDG, which has been shown to accumulate avidly in most tumors. (18)F-FDG PET is now routinely used in the diagnosis, staging, and posttherapy evaluation of oncologic patients. After reading this paper, the reader should understand the physiologic basis of using (18)F-FDG in patients with different tumors, describe the role of this radiopharmaceutical in the management of oncologic patients, and identify those malignancies for which (18)F-FDG has proved to be effective in diagnosis and follow-up.|*Fluorodeoxyglucose F18[MESH]|*Radiopharmaceuticals[MESH]|Colorectal Neoplasms/diagnostic imaging[MESH]|Female[MESH]|Genital Neoplasms, Female/diagnostic imaging[MESH]|Head and Neck Neoplasms/diagnostic imaging[MESH]|Humans[MESH]|Lung Neoplasms/diagnostic imaging[MESH]|Lymphoma/diagnostic imaging[MESH]|Melanoma/diagnostic imaging[MESH]|Skin Neoplasms/diagnostic imaging[MESH]|Tomography, Emission-Computed[MESH] |